218 related articles for article (PubMed ID: 22909227)
21. Can Genomic Amplification of Human Telomerase Gene and C-MYC in Liquid-Based Cytological Specimens Be Used as a Method for Opportunistic Cervical Cancer Screening?
Gao K; Eurasian M; Zhang J; Wei Y; Zheng Q; Ye H; Li L
Gynecol Obstet Invest; 2015; 80(3):153-63. PubMed ID: 25832290
[TBL] [Abstract][Full Text] [Related]
22. Clinical Role of the Detection of Human Telomerase RNA Component Gene Amplification by Fluorescence in situ Hybridization on Liquid-Based Cervical Samples: Comparison with Human Papillomavirus-DNA Testing and Histopathology.
Zappacosta R; Ianieri MM; Buca D; Repetti E; Ricciardulli A; Liberati M
Acta Cytol; 2015; 59(4):345-54. PubMed ID: 26343271
[TBL] [Abstract][Full Text] [Related]
23. [Detection of TERC gene amplification by fluorescence in-situ hybridization in cervical intraepithelial lesions].
YUAN YL; HE CN; XU MT; XU CQ; SUN YN; ZHAO HF; CHEN C
Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):182-6. PubMed ID: 21575390
[TBL] [Abstract][Full Text] [Related]
24. Gain of human telomerase RNA gene is associated with progression of cervical intraepithelial neoplasia grade I or II.
Lan YL; Yu L; Jia CW; Wu YM; Wang SY
Chin Med J (Engl); 2012 May; 125(9):1599-602. PubMed ID: 22800828
[TBL] [Abstract][Full Text] [Related]
25. Prospective study of hTERC gene detection by fluorescence in situ hybridization (FISH) in cervical intraepithelial neoplasia 1 natural prognosis.
Li L; Jiang W; Zeng SY; Li L
Eur J Gynaecol Oncol; 2014; 35(3):289-91. PubMed ID: 24984543
[TBL] [Abstract][Full Text] [Related]
26. Gain of the human telomerase RNA gene TERC at 3q26 is strongly associated with cervical intraepithelial neoplasia and carcinoma.
Sui W; Ou M; Dai Y; Chen J; Lan H; Yan Q; Huang H
Int J Gynecol Cancer; 2009 Nov; 19(8):1303-6. PubMed ID: 20009881
[TBL] [Abstract][Full Text] [Related]
27. Genomic amplification patterns of human telomerase RNA gene and C-MYC in liquid-based cytological specimens used for the detection of high-grade cervical intraepithelial neoplasia.
Chen S; Yang Z; Zhang Y; Qiao Y; Cui B; Zhang Y; Kong B
Diagn Pathol; 2012 Apr; 7():40. PubMed ID: 22500694
[TBL] [Abstract][Full Text] [Related]
28. Molecular cytogenetic analyses of hTERC (3q26) and MYC (8q24) genes amplifications in correlation with oncogenic human papillomavirus infection in Czech patients with cervical intraepithelial neoplasia and cervical carcinomas.
Kuglik P; Kasikova K; Smetana J; Vallova V; Lastuvkova A; Moukova L; Cvanova M; Brozova L
Neoplasma; 2015; 62(1):130-9. PubMed ID: 25563377
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of hTERC and C-Myc genes amplification in a group of Egyptian patients with cancer cervix.
Eid MM; Nossair HM; Ismael MT; Amira G; Hosney MM; Abdul Rahman R
Gulf J Oncolog; 2011 Jul; (10):18-26. PubMed ID: 21724525
[TBL] [Abstract][Full Text] [Related]
30. Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer.
Hopman AH; Theelen W; Hommelberg PP; Kamps MA; Herrington CS; Morrison LE; Speel EJ; Smedts F; Ramaekers FC
J Pathol; 2006 Dec; 210(4):412-9. PubMed ID: 17054308
[TBL] [Abstract][Full Text] [Related]
31. Cervical cytology by means of fluorescence in situ hybridization with a set of chromosome-specific DNA probes.
Hariu H; Matsuta M
J Obstet Gynaecol Res; 1996 Apr; 22(2):163-70. PubMed ID: 8697347
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus and human telomerase RNA component gene in cervical cancer progression.
Liu Y; Fan P; Yang Y; Xu C; Huang Y; Li D; Qing Q; Sun C; Zhou H
Sci Rep; 2019 Nov; 9(1):15926. PubMed ID: 31685833
[TBL] [Abstract][Full Text] [Related]
33. Gain of hTERC: a genetic marker of malignancy in oral potentially malignant lesions.
Dorji T; Monti V; Fellegara G; Gabba S; Grazioli V; Repetti E; Marcialis C; Peluso S; Di Ruzza D; Neri F; Foschini MP
Hum Pathol; 2015 Sep; 46(9):1275-81. PubMed ID: 26170010
[TBL] [Abstract][Full Text] [Related]
34. [hTERC gene amplification and expression of human papillomavirus in cervical carcinogenesis].
Li SH; Liu LL; Ma HX; Wang QH; Bai W
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):121-2. PubMed ID: 22455890
[No Abstract] [Full Text] [Related]
35. Establishment and analysis of the prediction model for cervical squamous cell carcinoma.
Zhou YH; Fan WF; Deng J; Xi HL
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5042-5048. PubMed ID: 29228452
[TBL] [Abstract][Full Text] [Related]
36. Human telomerase RNA component (hTERC) gene amplification detected by FISH in precancerous lesions and carcinoma of the larynx.
Liu Y; Dong XL; Tian C; Liu HG
Diagn Pathol; 2012 Mar; 7():34. PubMed ID: 22463766
[TBL] [Abstract][Full Text] [Related]
37. Application of human papillomavirus in screening for cervical cancer and precancerous lesions.
Wang JL; Yang YZ; Dong WW; Sun J; Tao HT; Li RX; Hu Y
Asian Pac J Cancer Prev; 2013; 14(5):2979-82. PubMed ID: 23803065
[TBL] [Abstract][Full Text] [Related]
38. Prediction of outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC.
Obermann EC; Savic Prince S; Barascud A; Grilli B; Herzog M; Kaup D; Cathomas G; Frey Tirri B; Zlobec I; Wight E; Bubendorf L
Cancer Cytopathol; 2013 Aug; 121(8):423-31. PubMed ID: 23408758
[TBL] [Abstract][Full Text] [Related]
39. Screening of TERC gene amplification as an additional genetic diagnostic test in detection of cervical preneoplastic lesions.
Kokalj-Vokac N; Kodric T; Erjavec-Skerget A; Zagorac A; Takac I
Cancer Genet Cytogenet; 2009 Nov; 195(1):19-22. PubMed ID: 19837263
[TBL] [Abstract][Full Text] [Related]
40. Study on the correlation between hTREC and HPV load and cervical CINI/II/III lesions and cervical cancer.
He H; Pan Q; Pan J; Chen Y; Cao L
J Clin Lab Anal; 2020 Jul; 34(7):e23257. PubMed ID: 32100923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
